The latest in RA therapies, and what you can expect from the pipeline.
There are roughly 100 autoimmune diseases, plus about 40 more that are immune-based.
High-cost treatments for rheumatoid arthritis has fueled the need to better understand their value to healthcare systems and patients.
More targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.